Sanara MedTech Inc.
SMTI
$22.93
-$0.24-1.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 63.06% | -5.06% | -28.60% | -7.83% | -75.27% |
| Total Depreciation and Amortization | 19.41% | 3.36% | -39.70% | -53.68% | -50.40% |
| Total Amortization of Deferred Charges | 1.89% | 28.78% | 84.71% | 81.06% | 2,507.23% |
| Total Other Non-Cash Items | 30.00% | 111.50% | 296.12% | 208.86% | 392.38% |
| Change in Net Operating Assets | -40.74% | 52.19% | 63.30% | 56.80% | 13.66% |
| Cash from Operations | 1,067.48% | 19,470.59% | 188.52% | 230.71% | 86.18% |
| Capital Expenditure | -1.82% | -1,712.09% | -1,887.81% | -918.38% | -511.14% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 78.66% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.65% | -10,150.52% | -- | -- | -- |
| Cash from Investing | 45.27% | -74.74% | -41.34% | -51.53% | -14.44% |
| Total Debt Issued | -100.17% | -13.51% | -13.51% | -48.72% | 172.11% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -166.95% | -77.89% | -1,229.02% | -413.75% | -7.41% |
| Cash from Financing | -109.33% | -44.36% | -54.72% | 72.75% | 237.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.41% | -74.66% | -93.21% | 11,895.89% | 500.60% |